Skip to main content

Table 3 Demographic data

From: The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study

Variables

Findings (n = 30)

Age (years), median (IQR)

35 (27–53)

Gender, n (%)

 Male

17(56.7%)

 Female

13(43.3%)

ASA-PS class, n (%)

 I

10 (33.3%)

 II

17 (56.7%)

 III

3 (10%)

BMI (kg/m2), mean ± SD

29.45 ± 5.56

Type of surgery, n (%)

 General

13 (43.3%)

 Urology

4 (13.3%)

 ENT

10 (33.3%)

 Plastic

2 (6.7%)

 OB/GYN

1 (3.3%)

NMBD used, n (%)

 Succinylcholine

1 (3.3%)

 Rocuronium

26 (86.7%)

 Cisatracurium

3 (10%)

Reversal used, n (%)

 None

7 (23.3%)

 Neostigmine

23 (76.7%)

  1. n (%) number (percentage), IQR interquartile range, ± SD ± standard deviation, ASA-PS class American Society of Anaesthesiologists Physical Status class, BMI body mass index, kg/m2 kilogramme per metre square, ENT ear, nose and throat, OB/GYN obstetrics and gynaecology, NMBD neuromuscular blocking drug